ProKidney Announces the Closing of $140 Million Public Offering of Class a Ordinary Shares and Concurrent Registered Direct Offering, Including Exercise of Underwriters’ Option
ProKidney宣佈關閉1.4億美元的A類普通股公開發售和登記直接發售,包括承銷商選擇權的行權。
ProKidney Announces the Closing of $140 Million Public Offering of Class a Ordinary Shares and Concurrent Registered Direct Offering, Including Exercise of Underwriters’ Option
ProKidney宣佈關閉1.4億美元的A類普通股公開發售和登記直接發售,包括承銷商選擇權的行權。
譯文內容由第三人軟體翻譯。